FSA Advisors Inc. acquired a new stake in shares of Ares Capital Corporation (NASDAQ:ARCC - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 24,369 shares of the investment management company's stock, valued at approximately $540,000.
Several other large investors have also bought and sold shares of ARCC. Thrivent Financial for Lutherans bought a new position in Ares Capital during the 4th quarter valued at $314,000. JPMorgan Chase & Co. raised its stake in shares of Ares Capital by 26.0% during the 4th quarter. JPMorgan Chase & Co. now owns 4,268,547 shares of the investment management company's stock worth $93,439,000 after purchasing an additional 881,450 shares during the period. Blair William & Co. IL raised its stake in shares of Ares Capital by 3.3% during the 4th quarter. Blair William & Co. IL now owns 280,705 shares of the investment management company's stock worth $6,145,000 after purchasing an additional 8,986 shares during the period. Brown Brothers Harriman & Co. raised its stake in shares of Ares Capital by 16.0% during the 4th quarter. Brown Brothers Harriman & Co. now owns 36,159 shares of the investment management company's stock worth $792,000 after purchasing an additional 4,980 shares during the period. Finally, CIBC Private Wealth Group LLC raised its stake in shares of Ares Capital by 0.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 443,747 shares of the investment management company's stock worth $9,802,000 after purchasing an additional 3,741 shares during the period. 27.38% of the stock is currently owned by institutional investors.
Ares Capital Stock Down 1.8%
Shares of ARCC opened at $22.70 on Tuesday. The firm has a market cap of $15.76 billion, a P/E ratio of 11.07 and a beta of 0.67. The stock has a 50 day simple moving average of $22.18 and a two-hundred day simple moving average of $22.04. The company has a debt-to-equity ratio of 1.02, a current ratio of 1.40 and a quick ratio of 1.40. Ares Capital Corporation has a 1 year low of $18.26 and a 1 year high of $23.84.
Ares Capital (NASDAQ:ARCC - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The investment management company reported $0.50 earnings per share for the quarter, missing the consensus estimate of $0.54 by ($0.04). Ares Capital had a net margin of 43.50% and a return on equity of 11.05%. The company had revenue of $599.00 million during the quarter, compared to the consensus estimate of $769.32 million. During the same quarter in the previous year, the firm posted $0.59 EPS. The business's revenue for the quarter was up 4.4% compared to the same quarter last year. On average, analysts forecast that Ares Capital Corporation will post 2.19 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on ARCC. Royal Bank Of Canada decreased their price objective on Ares Capital from $24.00 to $23.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. B. Riley raised Ares Capital to a "hold" rating in a report on Monday, June 16th. JPMorgan Chase & Co. reduced their target price on Ares Capital from $24.50 to $22.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Keefe, Bruyette & Woods reduced their target price on Ares Capital from $23.00 to $22.00 and set an "outperform" rating for the company in a report on Tuesday, April 8th. Finally, UBS Group lifted their target price on Ares Capital from $22.00 to $22.50 and gave the company a "neutral" rating in a report on Wednesday, July 16th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $22.21.
Read Our Latest Research Report on Ares Capital
Ares Capital Company Profile
(
Free Report)
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ares Capital, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ares Capital wasn't on the list.
While Ares Capital currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.